1. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK
2. Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
3. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
4. Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland
5. HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland
6. Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK
7. Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq
8. Istituto di Ricerche Farmacologiche “Mario Negri” IRCCS, Milan, Italy
9. Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia
10. Institute of Comparative Economic Studies, Hosei University Tokyo, Japan
11. Department of Global Health Economics and Policy, University of Kragujevac, Serbia
12. Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia
13. Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania
14. Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
15. Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
16. Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
17. Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina
18. Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria
19. State Institute for Drug Control, Prague, Czech Republic
20. Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic
21. State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia
22. Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany
23. Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary
24. Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary
25. Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo
26. Independent Consultant, Riga, Latvia
27. Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
28. Department of Health Services Management, University of Malta, Valletta, Malta
29. Medicines Committee, Oslo University Hospitals, Oslo, Norway
30. Faculty of Medicine, Public Health and Management Department, “Carol Davila” University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania
31. Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia
32. Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK
33. NHS Lothian, Edinburgh, UK
34. Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain
35. Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain
36. NEPI-Nätverk för Läkemedelsepidemiologi, Stockholm, Sweden
37. National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece
38. Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
39. Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK
40. NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK
41. Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden